Content about Pharmaceutical industry

March 18, 2010

Drug companies had better take a close look at their portfolios and make sure they...

WHAT IT MEANS AND WHY IT'S IMPORTANT Drug companies had better take a close look at their portfolios and make sure they aren’t marketing unapproved drugs. Any excuses they might have for making prescription drugs without regulatory approval will go unheeded by Food and Drug Administration officials.

(THE NEWS: FDA shuts down unapproved Glenmark, Konec drugs. For the full story, click here)

March 18, 2010

High doses of cholesterol drug may raise muscle injury risk, FDA warns

Patients taking a common drug for treating high cholesterol may be at increased risk of...

March 18, 2010

Valeant buys OTC, generic drug maker

A U.S. drug maker has bought a manufacturer of branded generics and OTC products in...

March 17, 2010

AstraZeneca wins Seroquel case

A state judge in New Jersey has ruled in favor of AstraZeneca in the case...

March 17, 2010

GPhA: Omission of 'pay-for-delay' deals in health bill 'good news for American consumers'

A ban on patent settlements between branded and generic drug companies appears to have been...

March 17, 2010

Lilly comments on drug theft at Connecticut facility

Drugs stolen from an Eli Lilly warehouse in Connecticut Sunday unlikely are to make it...

March 17, 2010

PhRMA names new chairman

The Pharmaceutical Research and Manufacturers of America elected Pfizer president and CEO Jeffrey Kindler as...

March 17, 2010

Roche calls its R&D status 'uniquely positioned'

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 17, 2010

Teva to acquire Ratiopharm

Teva Pharmaceutical Industries beat out Pfizer in the race to acquire German generic drug maker...

March 16, 2010

FDA shuts down unapproved Glenmark, Konec drugs

The Food and Drug Administration has ordered two generic drug companies to stop marketing unapproved...

March 16, 2010

MiddleBrook expanding promotion of Moxatag through IncreaseRx program

MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the...

WESTLAKE, Texas MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the drug maker announced Wednesday.

IncreaseRx is a virtual sales-contract organization that gives healthcare professionals access to electronic sampling, learning and education tools. The company has entered an agreement with DoctorDirectory.com, its promotion partner for Moxatag (amoxicillin), and plans to use Web-based educational and promotional tactics to reach prescribers with sales and marketing messages for the drug.

March 16, 2010

Pending court ruling, Teva to delay marketing Temodar generic

Teva Pharmaceutical Industries will start marketing its version of a brain tumor drug only if...

March 15, 2010

FDA issues complete response letter for MannKind's Afrezza

The Food and Drug Administration did not approve an application from MannKind Corp. for a...

March 15, 2010

Mylan, Takeda reach agreement on Actos, Actoplus Met patents

Mylan has settled patent litigation cases with Takeda concerning two diabetes drugs, the generic drug...

March 15, 2010

NCPA: Drug manufacturers should pay rebates in DoD's Tricare program

The National Community Pharmacists Association expressed support of the U.S. Department of Defense's efforts to...

March 15, 2010

Teva seeks to market Shire's ADHD drug

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...

March 15, 2010

Watson receives FDA approval for Cardizem LA generic

The Food and Drug Administration has approved a Watson Pharmaceuticals drug for hypertension, Watson announced...

March 14, 2010

Bausch & Lomb recruits two Schering-Plough leaders as CEO, chairman

Bausch & Lomb on Monday recruited two former Schering-Plough senior leaders to take the reigns...

March 14, 2010

FDA demands REMS for Bydureon

Drug makers Eli Lilly, Amylin Pharmaceuticals and Alkermes encountered a speed bump in their efforts...

March 14, 2010

Ranbaxy to launch generic Actos

India’s Ranbaxy Labs will launch a generic version of a diabetes drug in two years,...

March 14, 2010

Rx suppliers prepare for patent-protection storm

Drug companies stand to lose a lot of money in the coming years, as the...

March 11, 2010

Caraco launches colon, rectal cancer generic

Caraco Pharmaceutical Labs has launched a generic version of a drug for treating colon and...

March 11, 2010

CHPA president to retire, organization seeks new leader

Linda Suydam, Consumer Healthcare Products Association president, announced her retirement Friday morning at the over-the-counter...

March 10, 2010

FDA accepts approval application for lurasidone

The Food and Drug Administration has accepted an approval application for a new drug to...

March 10, 2010

Sanofi-Aventis completes acquisition of Chattem

A leading global pharmaceutical company has completed its acquisition of a consumer healthcare products manufacturer....